Latest Press Releases
- Adaptive Phage Therapeutics Announces First Patient Dosed in the PHAGE Clinical Trial
- Adaptive Phage Therapeutics Appoints Edward Fang as Chief Medical Officer
- Adaptive Phage Therapeutics Awarded Additional $5 Million from U.S. Defense Health Agency to Support Diabetic Foot Osteomyelitis Clinical Trial
- Adaptive Phage Therapeutics Announces “The AMR RAPID™ Challenge” for the Infectious Disease Research Community: Find a Bacteria Resistant to APT’s Investigational Phage Bank
- Adaptive Phage Therapeutics Announces First Patient Dosed in the DANCE Trial, a Phase 1/2 Study Evaluating APT Phage Bank in Diabetic Foot Osteomyelitis
- Adaptive Phage Therapeutics Appoints Rob Casper as Vice President of Clinical Operations
- Adaptive Phage Therapeutics Extends Series B to $61 million with Addition of The AMR Action Fund
- Adaptive Phage Therapeutics Announces Strategic Agreement with ARLG to Support Phase 1b/2 Cystic Fibrosis Study
- Adaptive Phage Therapeutics Awarded Additional $8 Million from U.S. Department of Defense for Clinical Advancement of Phage to Address Unmet Needs in Infectious Diseases
See all press releases